193 related articles for article (PubMed ID: 24804695)
1. Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial.
Gianatti EJ; Dupuis P; Hoermann R; Strauss BJ; Wentworth JM; Zajac JD; Grossmann M
Diabetes Care; 2014 Aug; 37(8):2098-107. PubMed ID: 24804695
[TBL] [Abstract][Full Text] [Related]
2. Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
Gianatti EJ; Dupuis P; Hoermann R; Zajac JD; Grossmann M
J Clin Endocrinol Metab; 2014 Oct; 99(10):3821-8. PubMed ID: 24978674
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
Kapoor D; Goodwin E; Channer KS; Jones TH
Eur J Endocrinol; 2006 Jun; 154(6):899-906. PubMed ID: 16728551
[TBL] [Abstract][Full Text] [Related]
4. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P;
J Sex Med; 2014 Mar; 11(3):840-56. PubMed ID: 24308723
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
Ng Tang Fui M; Prendergast LA; Dupuis P; Raval M; Strauss BJ; Zajac JD; Grossmann M
BMC Med; 2016 Oct; 14(1):153. PubMed ID: 27716209
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
[TBL] [Abstract][Full Text] [Related]
8. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
9. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
10. Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials.
Grossmann M; Hoermann R; Wittert G; Yeap BB
Clin Endocrinol (Oxf); 2015 Sep; 83(3):344-51. PubMed ID: 25557752
[TBL] [Abstract][Full Text] [Related]
11. [Testosterone Undecanoate Pills improves insulin resistance in type-2 diabetes men with hypogonadism].
DI HJ; Fan YF; Zhang HF; Liu KM; Liu C
Zhonghua Nan Ke Xue; 2017 Jun; 23(6):517-521. PubMed ID: 29722943
[TBL] [Abstract][Full Text] [Related]
12. Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes.
Gianatti EJ; Hoermann R; Lam Q; Dupuis P; Zajac JD; Grossmann M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):55-62. PubMed ID: 26120052
[TBL] [Abstract][Full Text] [Related]
13. Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trial.
Wittert G; Atlantis E; Allan C; Bracken K; Conway A; Daniel M; Gebski V; Grossmann M; Hague W; Handelsman DJ; Inder W; Jenkins A; Keech A; McLachlan R; Robledo K; Stuckey B; Yeap BB
Diabetes Obes Metab; 2019 Apr; 21(4):772-780. PubMed ID: 30520208
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients.
van Eyk HJ; Paiman EHM; Bizino MB; de Heer P; Geelhoed-Duijvestijn PH; Kharagjitsingh AV; Smit JWA; Lamb HJ; Rensen PCN; Jazet IM
Cardiovasc Diabetol; 2019 Jul; 18(1):87. PubMed ID: 31288820
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.
Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H
BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527
[TBL] [Abstract][Full Text] [Related]
16. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.
Dimitriadis GK; Randeva HS; Aftab S; Ali A; Hattersley JG; Pandey S; Grammatopoulos DK; Valsamakis G; Mastorakos G; Jones TH; Barber TM
Endocrine; 2018 Apr; 60(1):175-184. PubMed ID: 29396841
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
Tishova Y; Kalinchenko S; Mskhalaya G; Hackett G; Livingston M; König C; Strange R; Zitzmann M; Mann A; Maarouf A; Ramachandran S
Diabetes Obes Metab; 2024 Jun; 26(6):2147-2157. PubMed ID: 38433502
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
20. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
